Abstract
Tissue homeostasis is maintained by tight control of signaling events that regulate cell death and cell survival. Apoptosis or programmed cell death plays a key role in maintaining tissue homeostasis under various conditions during normal development and in the adult organism. Thus, defective apoptosis programs contribute to the pathogenesis of various human diseases, for example to cancer formation. In addition, the antitumor activity of most cancer therapies, including chemotherapy, radiotherapy or immunotherapy, is mediated by the activation of apoptosis in cancer cells. Natural compounds including resveratrol have attracted much attention over the last decade both as cancer chemopreventive agents and as cancer therapeutics. To this end, resveratrol inhibits signal transduction pathways that block apoptosis and/or promote cell survival. Insights into the molecular mechanisms of how resveratrol regulates cell survival and cell death signaling is expected to open new avenues for the exploitation of resveratrol in the prevention and treatment of cancer.
Keywords: Apoptosis, resveratrol, cancer
Mini-Reviews in Organic Chemistry
Title: Regulation of Apoptosis and Cell Survival by Resveratrol
Volume: 7 Issue: 4
Author(s): Simone Fulda
Affiliation:
Keywords: Apoptosis, resveratrol, cancer
Abstract: Tissue homeostasis is maintained by tight control of signaling events that regulate cell death and cell survival. Apoptosis or programmed cell death plays a key role in maintaining tissue homeostasis under various conditions during normal development and in the adult organism. Thus, defective apoptosis programs contribute to the pathogenesis of various human diseases, for example to cancer formation. In addition, the antitumor activity of most cancer therapies, including chemotherapy, radiotherapy or immunotherapy, is mediated by the activation of apoptosis in cancer cells. Natural compounds including resveratrol have attracted much attention over the last decade both as cancer chemopreventive agents and as cancer therapeutics. To this end, resveratrol inhibits signal transduction pathways that block apoptosis and/or promote cell survival. Insights into the molecular mechanisms of how resveratrol regulates cell survival and cell death signaling is expected to open new avenues for the exploitation of resveratrol in the prevention and treatment of cancer.
Export Options
About this article
Cite this article as:
Fulda Simone, Regulation of Apoptosis and Cell Survival by Resveratrol, Mini-Reviews in Organic Chemistry 2010; 7 (4) . https://dx.doi.org/10.2174/157019310792246355
DOI https://dx.doi.org/10.2174/157019310792246355 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Research Progress of PARP Inhibitor Monotherapy and Combination
Therapy for Endometrial Cancer
Current Drug Targets Function of miRNA in Controlling Drug Resistance of Human Cancers
Current Drug Targets Anticancer Mechanisms of Berberine: A Good Choice for Glioblastoma Multiforme Therapy
Current Medicinal Chemistry Histone Deacetylase Inhibitors: An Attractive Strategy for Cancer Therapy
Current Medicinal Chemistry Role of the Renin-Angiotensin System in Gynecologic Cancers
Current Cancer Drug Targets The Role of Blood-Brain Barrier Transporters in Pathophysiology and Pharmacotherapy of Stroke
Current Pharmaceutical Design Targeting Proteasomes with Naturally Occurring Compounds in Cancer Treatment
Current Cancer Drug Targets ELISA-based Protein Arrays: Multiplexed Sandwich Immunoassays
Current Proteomics Developments of Polo-like Kinase 1 (Plk1) Inhibitors as Anti-Cancer Agents
Mini-Reviews in Medicinal Chemistry Imaging Features of Carcinosarcoma Arising from Adenofibroma of the Uterus: A Case Report
Current Medical Imaging 1α ,25(OH)2-Vitamin D3 and 17β-Estradiol: Two Steroid Partners Acting in Skeletal Muscle
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Polycystic Ovary Syndrome: A Contemporary Clinical Approach
Current Pharmaceutical Design Single-Photon Emission Computed Tomography Tracers for Predicting and Monitoring Cancer Therapy
Current Pharmaceutical Biotechnology Tyrosine Kinases as Molecular Targets to Inhibit Cancer Progression and Metastasis
Current Pharmaceutical Design The Chemosensitizing Role of Metformin in Anti-Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Apoptosis-related BCL2-family Members: Key Players in Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Meta-analysis Reveals No Association of DNMT3B -149 C>T Gene Polymorphism With Overall Cancer Risk
Current Genomics The mTOR Pathway: A New Target in Cancer Therapy
Current Cancer Drug Targets Novel Approaches to the Treatment of Obesity and Type 2 Diabetes Mellitus: Bioactive Leptin-Related Synthetic Peptide Analogs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Current WHO Classification of Tumours of the Central Nervous System: Histopathology and Additional Diagnostic Methods
Current Medical Imaging